For subscribers
New technique to help boost research in immunotherapy
A*Star spin-off hopes it will help in developing drugs for cancer, other diseases
Sign up now: Get ST's newsletters delivered to your inbox
Co-founders of Immunoscape, (clockwise from front right) Dr Alessandra Nardin, Dr Michael Fehlings, Dr Evan Newell and Mr Ng Choon Peng.
ST PHOTO: SYAMIL SAPARI
Biotechnology firm Immunoscape has come up with a technique that can help researchers and clinicians develop drugs for use in immunotherapy in the fight against cancer and other diseases.
The company - a spin-off of the Agency for Science, Technology and Research (A*Star) - uses the method, a form of immune profiling, to create maps of T-cells which help to regulate the body's immune response to diseases. There are millions of such cells, which can kill tumours or viruses.
